Notizia - Recent Pharma, Healthcare and Biotech Happenings

spartalizumab failure

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Novartis’s Spartalizumab Combo Stumbles; Union Therapeutics Doses In COVID-19 Trial; Yumanity To Merge With Proteostasis

Explore More...

SEC scrutinizes; Acacia meets endpoint; Axovant’s dementia drug; Novartis expands; Aurobindo responds

AMRI enters alliance; Ferring and Enteris deal; Quotient Clinical Acquires; Renova takes over Rights

FDA approves; Sun Pharma Recalls; Mezzion filed; Sanofi’s antibody to treat

ALCMI, ALCF and Scancell partner; Sun unloads Ohm Labs plants; Takeda and Ovid join; Guardant and MD Anderson collaborate; Glooko and Ascensia integrate

AstraZeneca announces; Trivitron launches; BrainStorm Cell Therapeutics validates

Payers block EpiPen; Allergan charged; AbbVie’s Humira; Baxter paying $18M

U.K. weighs drug rationing; Applying Digital; FDA slaps Florida

Astellas ditches UMN Pharma; J&J, Actelion land on a price; Bayer’s pledge; Biogen to fork over $1.25B-plus

FDA accepts; Keytruda takes lead; M Pharmaceutical develops; Merck Deploys Palantir

Aurobindo takes top generic spot; Valeant unloads Dendreon; Ipsen strikes $1B deal; Takeda shells out $5.2B

Sanofi, Regeneron one step closer; Pharma’s deal; J&J and Actelion deal

Sanofi sues Novo; Allergan gets help; Actelion snubs; Impax CEO Wilkinson out

Pfizer uses; FDA approves; EMA approves; Mylan launches

CDC study reveals; Jevtana receives yes; Herantis secures; Immuno-oncology is not cost-effective

Novartis joins; Sanofi weighs Actelion; Valeant and Takeda’s $10B deal; Astellas scouts pipeline

Glaxo replaces ViiV; Lilly nets; AstraZeneca shuffles off; Gazyva aims to beat

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader